Moxalactam therapy of Haemophilus influenzae type b meningitis in children (Q40828835)

24 September 2017

title

Moxalactam therapy of Haemophilus influenzae type b meningitis in children (English)

1 reference

24 September 2017

1 reference

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

Chartrand SA

1

1 reference

24 September 2017

Marks MI

2

1 reference

24 September 2017

Scribner RK

3

1 reference

24 September 2017

Johnston JT

4

1 reference

24 September 2017

Frederick DF

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 March 1984

1 reference

The Journal of Pediatrics

24 September 2017

published in

1 reference

24 September 2017

volume

104

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

454-459

1 reference

Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

Clinical and pharmacokinetic evaluation of parenteral moxalactam in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

Relation of concentrations of Haemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2981116-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(84)81116-6

1 reference

24 September 2017

1 reference